NO20016109L - Purinderivater - Google Patents

Purinderivater

Info

Publication number: NO20016109L
Authority: NO; Norway
Prior art keywords: purine derivatives; purine; derivatives
Prior art date: 1999-06-15

Application number

NO20016109A

Other languages

English (en)

Norwegian (no)

Other versions

NO20016109D0 (no

Inventor

Simon John Mantell

Sandra Marina Monaghan

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-15

Filing date

2001-12-14

Publication date

2002-02-15

2001-12-14 Application filed by Pfizer filed Critical Pfizer

2001-12-14 Publication of NO20016109D0 publication Critical patent/NO20016109D0/no

2002-02-15 Publication of NO20016109L publication Critical patent/NO20016109L/no

Links

229940083251 peripheral vasodilators purine derivative Drugs 0.000 title 1
125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Hematology (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Otolaryngology (AREA)
Communicable Diseases (AREA)

NO20016109A 1999-06-15 2001-12-14 Purinderivater NO20016109L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9913932.1A GB9913932D0 (en)	1999-06-15	1999-06-15	Purine derivatives
PCT/IB2000/000789 WO2000077018A2 (fr)	1999-06-15	2000-06-13	Derives de purine

Publications (2)

Publication Number	Publication Date
NO20016109D0 NO20016109D0 (no)	2001-12-14
NO20016109L true NO20016109L (no)	2002-02-15

Family

ID=10855403

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20016109A NO20016109L (no)	1999-06-15	2001-12-14	Purinderivater

Country Status (38)

Country	Link
US (2)	US6900309B1 (fr)
EP (1)	EP1185542A2 (fr)
JP (1)	JP2003502339A (fr)
KR (1)	KR20020010707A (fr)
CN (1)	CN1179970C (fr)
AP (1)	AP2001002361A0 (fr)
AR (1)	AR024345A1 (fr)
AU (1)	AU764106B2 (fr)
BG (1)	BG106289A (fr)
BR (1)	BR0011705A (fr)
CA (1)	CA2379786C (fr)
CZ (1)	CZ20014397A3 (fr)
DZ (1)	DZ3168A1 (fr)
EA (1)	EA004861B1 (fr)
EC (1)	ECSP003531A (fr)
EE (1)	EE200100681A (fr)
GB (1)	GB9913932D0 (fr)
GT (1)	GT200000096A (fr)
HN (1)	HN2000000097A (fr)
HR (1)	HRP20010927A2 (fr)
HU (1)	HUP0203419A3 (fr)
IL (1)	IL147098A0 (fr)
IS (1)	IS6196A (fr)
MA (1)	MA26799A1 (fr)
MX (1)	MXPA01013094A (fr)
NO (1)	NO20016109L (fr)
NZ (1)	NZ516094A (fr)
OA (1)	OA11968A (fr)
PA (1)	PA8497001A1 (fr)
PE (1)	PE20010430A1 (fr)
PL (1)	PL354367A1 (fr)
SK (1)	SK18192001A3 (fr)
SV (1)	SV2001000100A (fr)
TN (1)	TNSN00133A1 (fr)
TR (1)	TR200103607T2 (fr)
UY (1)	UY26204A1 (fr)
WO (1)	WO2000077018A2 (fr)
ZA (1)	ZA200110208B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2264826T3 (es) *	1998-10-16	2007-01-16	Pfizer Inc.	Derivados de adenina.
GB9913932D0 (en) *	1999-06-15	1999-08-18	Pfizer Ltd	Purine derivatives
GB9924361D0 (en)	1999-10-14	1999-12-15	Pfizer Ltd	Purine derivatives
GB0003960D0 (en)	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives
TWI227240B (en) *	2000-06-06	2005-02-01	Pfizer	2-aminocarbonyl-9H-purine derivatives
US6753322B2 (en) *	2000-06-06	2004-06-22	Pfizer Inc	2-aminocarbonyl-9H-purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
GB0015727D0 (en) *	2000-06-27	2000-08-16	Pfizer Ltd	Purine derivatives
GB0022695D0 (en)	2000-09-15	2000-11-01	Pfizer Ltd	Purine Derivatives
GB0104555D0 (en) *	2001-02-23	2001-04-11	Glaxo Group Ltd	New Therapeutic method
WO2002072067A2 (fr) *	2001-03-12	2002-09-19	Glaxo Group Limited	Formulation aerosol pharmaceutique
GB0129273D0 (en) *	2001-12-06	2002-01-23	Pfizer Ltd	Crystalline drug form
GB0129397D0 (en) *	2001-12-07	2002-01-30	Pfizer Ltd	Pharmaceutical combination
GB0228723D0 (en)	2002-12-09	2003-01-15	Cambridge Biotechnology Ltd	Treatment of pain
AR044519A1 (es)	2003-05-02	2005-09-14	Novartis Ag	Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
WO2005019238A1 (fr) *	2003-08-22	2005-03-03	Meiji Seika Kaisha, Ltd.	Nouveaux derives d'azalide et d'azalactam et procede permettant de produire ces derives
JP2005132767A (ja) *	2003-10-30	2005-05-26	Sumitomo Chemical Co Ltd	プリン化合物の製造方法
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
TWI346109B (en)	2004-04-30	2011-08-01	Otsuka Pharma Co Ltd	4-amino-5-cyanopyrimidine derivatives
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0500785D0 (en) *	2005-01-14	2005-02-23	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
EP2532677A1 (fr)	2005-10-21	2012-12-12	Novartis AG	Anticorps humains dirigés contre l'IL -13 et utilisations thérapeutiques
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
CA2640089C (fr) *	2006-02-03	2013-07-23	Cv Therapeutics, Inc.	Procede de preparation d'un agoniste de recepteur a2a-adenosine et ses polymorphes
JP2010504933A (ja)	2006-09-29	2010-02-18	ノバルティスアーゲー	Ｐｉ３ｋ脂質キナーゼ阻害剤としてのピラゾロピリミジン
BRPI0718266A2 (pt)	2006-10-30	2014-01-07	Novartis Ag	Compostos heterocíclicos como agentes anti-inflamatórios.
JP5584138B2 (ja)	2008-01-11	2014-09-03	ノバルティスアーゲー	キナーゼ阻害剤としてのピリミジン類
ES2396023T3 (es)	2009-01-29	2013-02-18	Novartis Ag	Bencimidazoles sustituidos para el tratamiento de astrocitomas
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
BR112012003262A8 (pt)	2009-08-12	2016-05-17	Novartis Ag	compostos de hidrazona heterocíclica e seus usos para tratar câncer e inflamação
UA111579C2 (uk)	2009-08-17	2016-05-25	Інтеллікіне Ллк	ГЕТЕРОЦИКЛІЧНІ ПОХІДНІ 2-АМІНОБЕНЗО[d]ОКСАЗОЛУ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ ЗАХВОРЮВАННЯ, ПОВ'АНОГО З РІ3-КІНАЗОЮ
IN2012DN01453A (fr)	2009-08-20	2015-06-05	Novartis Ag
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (fr)	2010-09-09	2012-03-15	Irm Llc	Composés et compositions comme inhibiteurs de trk
WO2012107500A1 (fr)	2011-02-10	2012-08-16	Novartis Ag	Composés de [1, 2, 4] triazolo [4, 3 -b] pyridazine en tant qu'inhibiteurs de la tyrosine kinase c-met
WO2012116237A2 (fr)	2011-02-23	2012-08-30	Intellikine, Llc	Composés hétérocycliques et leurs utilisations
BR112013021638A2 (pt)	2011-02-25	2016-08-02	Irm Llc	"compostos inibidores de trk, seu uso e composições que os compreendem"
UY34329A (es)	2011-09-15	2013-04-30	Novartis Ag	Compuestos de triazolopiridina
US9174994B2 (en)	2011-11-23	2015-11-03	Intellikine, Llc	Enhanced treatment regimens using mTor inhibitors
MX371119B (es)	2012-04-03	2020-01-17	Novartis Ag	Productos de combinacion con los inhibidores de cinasa de tirosina y su uso.
HK1219421A1 (zh)	2013-03-15	2017-04-07	因特利凯有限责任公司	激酶抑制剂的组合及其用途
TW201605450A (zh)	2013-12-03	2016-02-16	諾華公司	Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
WO2016011658A1 (fr)	2014-07-25	2016-01-28	Novartis Ag	Polythérapie
US10195208B2 (en)	2014-07-31	2019-02-05	Novartis Ag	Combination therapy
EP3801069A4 (fr)	2018-06-01	2022-03-16	Cornell University	Polythérapie pour maladie ou trouble associé à pi3k
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5536419A (en)	1978-09-08	1980-03-14	Yamasa Shoyu Co Ltd	2-substituted adenosine derivative and its preparation
JPS55153789A (en) *	1979-04-11	1980-11-29	Sankyo Co Ltd	Penem-3-carboxylic acid derivative and its preparation
JPS55153798A (en) *	1979-05-18	1980-11-29	Kikkoman Corp	Novel 2-substituted-adenosine 3',5'-cyclic phosphate and its preparation
JPH0313934A (ja) *	1989-06-12	1991-01-22	Konica Corp	ハロゲン化銀写真感光材料
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5705491A (en)	1992-10-27	1998-01-06	Nippon Zoki Pharmaceutical Co., Ltd.	Adenosine deaminase inhibitor
DK155292D0 (da)	1992-12-23	1992-12-23	Novo Nordisk As	Kemiske forbindelser, deres fremstilling og anvendelse
JP3362291B2 (ja) *	1993-10-06	2003-01-07	コニカ株式会社	ハロゲン化銀写真感光材料及び画像形成方法
EP1366777B1 (fr) *	1995-04-14	2005-06-15	SmithKline Beecham Corporation	Inhalateur doseur de salmétérol
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
ZA9810490B (en)	1997-12-03	1999-05-20	Dainippon Pharmaceutical Co	2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
US6232297B1 (en)	1999-02-01	2001-05-15	University Of Virginia Patent Foundation	Methods and compositions for treating inflammatory response
RU2258071C2 (ru)	1999-05-24	2005-08-10	Юниверсити Оф Вирджиния Пэйтент Фаундейшн	Производные 2-алкиниладенозина для борьбы с воспалительной реакцией
GB9913932D0 (en) *	1999-06-15	1999-08-18	Pfizer Ltd	Purine derivatives
GB0003960D0 (en) *	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives

1999
- 1999-06-15 GB GBGB9913932.1A patent/GB9913932D0/en not_active Ceased
2000
- 2000-06-08 US US09/590,585 patent/US6900309B1/en not_active Expired - Fee Related
- 2000-06-13 HU HU0203419A patent/HUP0203419A3/hu unknown
- 2000-06-13 CA CA002379786A patent/CA2379786C/fr not_active Expired - Fee Related
- 2000-06-13 CN CNB008130647A patent/CN1179970C/zh not_active Expired - Fee Related
- 2000-06-13 HR HR20010927A patent/HRP20010927A2/hr not_active Application Discontinuation
- 2000-06-13 KR KR1020017016127A patent/KR20020010707A/ko not_active Ceased
- 2000-06-13 WO PCT/IB2000/000789 patent/WO2000077018A2/fr not_active Ceased
- 2000-06-13 AU AU49443/00A patent/AU764106B2/en not_active Ceased
- 2000-06-13 UY UY26204A patent/UY26204A1/es not_active Application Discontinuation
- 2000-06-13 HN HN2000000097A patent/HN2000000097A/es unknown
- 2000-06-13 IL IL14709800A patent/IL147098A0/xx unknown
- 2000-06-13 NZ NZ516094A patent/NZ516094A/en unknown
- 2000-06-13 JP JP2001503875A patent/JP2003502339A/ja not_active Ceased
- 2000-06-13 CZ CZ20014397A patent/CZ20014397A3/cs unknown
- 2000-06-13 SK SK1819-2001A patent/SK18192001A3/sk unknown
- 2000-06-13 PE PE2000000582A patent/PE20010430A1/es not_active Application Discontinuation
- 2000-06-13 AP APAP/P/2001/002361A patent/AP2001002361A0/en unknown
- 2000-06-13 OA OA1200100332A patent/OA11968A/en unknown
- 2000-06-13 BR BR0011705-6A patent/BR0011705A/pt not_active IP Right Cessation
- 2000-06-13 TR TR2001/03607T patent/TR200103607T2/xx unknown
- 2000-06-13 DZ DZ003168A patent/DZ3168A1/fr active
- 2000-06-13 MX MXPA01013094A patent/MXPA01013094A/es active IP Right Grant
- 2000-06-13 PL PL00354367A patent/PL354367A1/xx not_active Application Discontinuation
- 2000-06-13 EP EP00931495A patent/EP1185542A2/fr not_active Withdrawn
- 2000-06-13 EE EEP200100681A patent/EE200100681A/xx unknown
- 2000-06-13 EA EA200101203A patent/EA004861B1/ru not_active IP Right Cessation
- 2000-06-13 AR ARP000102905A patent/AR024345A1/es unknown
- 2000-06-14 SV SV2000000100A patent/SV2001000100A/es unknown
- 2000-06-14 EC EC2000003531A patent/ECSP003531A/es unknown
- 2000-06-14 TN TNTNSN00133A patent/TNSN00133A1/fr unknown
- 2000-06-14 GT GT200000096A patent/GT200000096A/es unknown
- 2000-06-14 PA PA20008497001A patent/PA8497001A1/es unknown
2001
- 2001-12-11 IS IS6196A patent/IS6196A/is unknown
- 2001-12-12 MA MA26440A patent/MA26799A1/fr unknown
- 2001-12-12 ZA ZA200110208A patent/ZA200110208B/xx unknown
- 2001-12-14 NO NO20016109A patent/NO20016109L/no not_active Application Discontinuation
2002
- 2002-01-08 BG BG06289A patent/BG106289A/xx unknown
2005
- 2005-01-24 US US11/042,582 patent/US20050124574A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2003502339A (ja)	2003-01-21
IS6196A (is)	2001-12-11
EA004861B1 (ru)	2004-08-26
EP1185542A2 (fr)	2002-03-13
BG106289A (en)	2002-09-30
HK1047111A1 (en)	2003-02-07
US20050124574A1 (en)	2005-06-09
SK18192001A3 (sk)	2003-04-01
AU764106B2 (en)	2003-08-07
HUP0203419A3 (en)	2005-02-28
SV2001000100A (es)	2001-11-08
MXPA01013094A (es)	2002-06-04
KR20020010707A (ko)	2002-02-04
CN1374966A (zh)	2002-10-16
IL147098A0 (en)	2002-08-14
WO2000077018A3 (fr)	2001-12-06
US6900309B1 (en)	2005-05-31
HN2000000097A (es)	2001-03-14
ECSP003531A (es)	2002-01-25
CA2379786C (fr)	2006-11-28
NZ516094A (en)	2004-07-30
CN1179970C (zh)	2004-12-15
AR024345A1 (es)	2002-10-02
HRP20010927A2 (en)	2003-04-30
BR0011705A (pt)	2002-03-26
CA2379786A1 (fr)	2000-12-21
PE20010430A1 (es)	2001-04-14
TR200103607T2 (tr)	2002-10-21
AU4944300A (en)	2001-01-02
TNSN00133A1 (fr)	2002-05-30
WO2000077018A2 (fr)	2000-12-21
DZ3168A1 (fr)	2000-12-21
UY26204A1 (es)	2001-01-31
AP2001002361A0 (en)	2001-12-31
HUP0203419A2 (hu)	2003-02-28
ZA200110208B (en)	2002-12-12
PL354367A1 (en)	2004-01-12
GB9913932D0 (en)	1999-08-18
OA11968A (en)	2006-04-17
PA8497001A1 (es)	2001-12-14
EE200100681A (et)	2003-04-15
GT200000096A (es)	2001-12-06
EA200101203A1 (ru)	2002-06-27
MA26799A1 (fr)	2004-12-20
NO20016109D0 (no)	2001-12-14
CZ20014397A3 (cs)	2003-04-16

Legal Events

Date	Code	Title	Description
2006-07-10	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
ATE321065T1 (de)	2006-04-15	Purin-derivate
DK1220863T3 (da)	2003-08-11	Purinderivater
IS6196A (is)	2001-12-11	Púrín afleiður
NO20010743D0 (no)	2001-02-14	Antivirale indoloksoacetyl-piperazin-derivater
ATE325807T1 (de)	2006-06-15	Purinderivate
DK1296996T3 (da)	2004-08-16	Purinderivater
ATE293104T1 (de)	2005-04-15	Thiazolylamid-derivate
ATE263748T1 (de)	2004-04-15	Admantan-derivate
ATE431356T1 (de)	2009-05-15	2-aminocarbonyl-9h-purinderivative
ATE257148T1 (de)	2004-01-15	Propargyletherderivate
ATE374747T1 (de)	2007-10-15	Monofluoralkylderivate
DK1154988T3 (da)	2004-11-22	Mevinolinderivater
ATE293592T1 (de)	2005-05-15	Resorcinderivate
DE60006703D1 (de)	2003-12-24	4-hydroxybiphenylhydrazid-derivate
DE60025348D1 (de)	2006-03-30	Ethansulfonyl-piperidin-derivate
NO20022867D0 (no)	2002-06-14	Syklopentenon-derivater
DE60001736D1 (de)	2003-04-24	1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
DE59909774D1 (de)	2004-07-22	1-cycloalkylpyrazolyl-benzoyl-derivate
DK1090019T3 (da)	2005-02-07	Adenosinderivater